Hsp90 pipline
Selected compounds targeting heat shock protein 90 (Hsp90) in clinical development for cancer
Company Product Formulation Indication Status
Kosan (NASDAQ:KOSN) Tanespimycin (KOS-953) IV Multiple myeloma (MM), Ph III (MM),